Cargando…
GnRHa for Ovarian Protection and the Association between AMH and Ovarian Function during Adjuvant Chemotherapy for Breast Cancer
Background: Chemotherapy impairs ovarian function in premenopausal breast cancer patients. Many breast cancer patients experience menopause earlier and therefore lose their reproductive abilities. The protective effect of gonadotropin-releasing hormone agonist (GnRha) upon the ovary is clearly appar...
Autores principales: | Zhong, Ying, Lin, Yan, Cheng, Xinqi, Huang, Xin, Zhou, Yidong, Mao, Feng, Wang, Yajing, Guan, Jinghong, Shen, Songjie, Xu, Yali, Peng, Li, li, Yan, Cao, Xi, Sun, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691711/ https://www.ncbi.nlm.nih.gov/pubmed/31413747 http://dx.doi.org/10.7150/jca.31859 |
Ejemplares similares
-
Fertility preservation and GnRHa for chemotherapy: debate
por: Blumenfeld, Zeev
Publicado: (2014) -
GnRHa protects the ovarian reserve by reducing endoplasmic reticulum stress during cyclophosphamide-based chemotherapy
por: Li, Xiaolin, et al.
Publicado: (2021) -
GnRHa trigger—the story of the ugly duckling
por: Humaidan, Peter, et al.
Publicado: (2023) -
The Luteal Phase after GnRHa Trigger-Understanding
An Enigma
por: Leth-Moller, Kathrine, et al.
Publicado: (2014) -
Treatment of central precocious puberty using low dose GnRH analogs (GnRHa)
por: Jahagirdar, Rahul, et al.
Publicado: (2015)